Archives
-
Ionizing Radiation and Altered Neural Differentiation
2026-09-03
Eom et al. showed that ionizing radiation does more than reduce neural stem-cell survival: in C17.2 cells, it promotes an altered neuronal differentiation program characterized by increased neurite outgrowth, neuronal markers, and glutamate-receptor expression. The study links this response to coordinated PI3K-STAT3-mGluR1 and PI3K-p53 signaling, providing a mechanistic framework for radiation-associated neural dysfunction.
-
2-NBDG Glucose Uptake Assay Kit for HCC Metabolism
2026-09-03
Map cellular glucose uptake without radioactivity while testing metabolic differences between sorafenib-sensitive and resistant hepatocellular carcinoma models. This single-cell-compatible workflow adds a functional glucose-transport readout to lipid metabolism, ferroptosis, and treatment-response studies.
-
GI 254023X: ADAM10 Inhibitor Workflows
2026-09-02
GI 254023X combines nanomolar ADAM10 potency with strong ADAM17 selectivity for mechanistic studies of Notch1 signaling, Jurkat-cell phenotypes, and endothelial barrier injury. This workflow-focused guide connects target-proximal cleavage assays with functional readouts for more reproducible preclinical research.
-
Forsythoside E: PKM2 Workflow for Liver Injury
2026-09-02
Forsythoside E is a mechanistically distinctive tool for connecting PKM2 tetramerization with macrophage metabolism, STAT3 signaling, and anti-inflammatory polarization. This workflow translates the compound’s validated binding and dose ranges into practical cell-based, biochemical, and mouse-study decisions for sepsis-induced liver injury research.
-
CENPI Drives Breast Cancer via Wnt/β-Catenin
2026-09-01
Wu and colleagues identify centromere protein I (CENPI) as an overexpressed breast cancer driver associated with disease progression and unfavorable prognosis. Using clinical datasets, cellular and xenograft models, RNA sequencing, and Wnt/β-catenin reporter assays, the study connects CENPI activity with malignant phenotypes and provides a framework for investigating its regulatory mechanism.
-
GDC-0994: A Causal ERK1/2 Assay Framework
2026-09-01
GDC-0994 is a selective ERK1/2 inhibitor for connecting target engagement with pathway control and measurable biological rescue. This article presents a cross-model assay framework that distinguishes ERK phosphorylation inhibition from genuine effects on tumor or hepatic phenotypes.
-
SIRT4–GDH Control of Liver Fibrosis
2026-08-31
The reference study identifies glutamine catabolism in hepatic stellate cells as a metabolic dependency that sustains fibrotic activation. Its central finding is that reduced SIRT4 activity permits GDH-driven glutamate utilization, whereas GDH inhibition or SIRT4 restoration suppresses stellate-cell proliferation and liver fibrosis.
-
BPEP-EM Hydrogel for Bacterial Keratitis
2026-08-31
Zheng and colleagues developed a thermosensitive BPOSS–BPEP hybrid hydrogel that improves erythromycin solubility, ocular retention, and antibacterial activity in a mouse model of Staphylococcus aureus keratitis. The study illustrates how material design can address topical antibiotic washout while retaining attention to biocompatibility and translational limitations.
-
Budesonide Assay Design for Airway Models
2026-08-30
Budesonide is a versatile anti-inflammatory corticosteroid for connecting glucocorticoid pharmacology with pulmonary assay design. This article explains how biomimetic chromatography can guide, rather than replace, asthma inflammation model selection and airway exposure studies.
-
HotStart Universal 2X FAST Green qPCR Guide
2026-08-29
HotStart Universal 2X FAST Green qPCR Master Mix is a dye-based, fast qPCR reagent for DNA and cDNA amplification. Its hot-start fast Taq polymerase, Green I fluorescence, and ROX reference dye support rapid gene expression analysis, while melt curve analysis remains necessary for specificity assessment.
-
Valemetostat and the Next Logic of EZH2 Inhibition
2026-08-28
Valemetostat (DS-3201) illustrates why lymphoma epigenetic therapy is moving beyond single-enzyme inhibition. This thought-leadership analysis connects PRC2 biology, EZH2-mutant pharmacology, assay design, clinical evidence, and translational decision-making for follicular lymphoma, diffuse large B-cell lymphoma, and related research programs.
-
Mavorixafor hydrochloride in Cell Assays
2026-08-28
Learn how Mavorixafor hydrochloride, SKU A3174, can be integrated into cell viability, proliferation, and cytotoxicity workflows without confusing CXCR4 pathway modulation with nonspecific cell death. This scenario-based guide covers formulation, controls, assay optimization, interpretation, and practical vendor selection.
-
Dimetridazole: From Assay Signal to Mechanism
2026-08-27
Dimetridazole, also known as 1,2-Dimethyl-5-nitroimidazole, is best interpreted through an evidence chain linking antimicrobial activity, quorum sensing, biofilms, and chemical transformation. This guide combines assay design with environmental-fate insights to help researchers distinguish true biological effects from concentration, matrix, and degradation artifacts.
-
Cyclic di-GMP: A Two-System Research Lens
2026-08-27
Cyclic di-GMP is an intracellular second messenger that connects bacterial persistence biology with STING-focused immune modulation research. This article develops an assay-centered framework for separating its antitoxin function in biofilms from its use in cancer immunotherapy studies.
-
HotStart Universal 2X FAST Green qPCR Master Mix
2026-08-26
Build rapid, reproducible RT-qPCR workflows for studying hly-linked biofilm phenotypes in Listeria monocytogenes. This guide combines hot-start specificity, fixed ROX normalization, fast cycling, and melt-curve verification for microbial gene expression analysis.